查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1192973

含銀傷口敷料市場：按產品類型,治療方法,最終用戶分類：2021-2031 年全球機遇分析和行業預測

Silver Wound Dressings Market By Product Type, By Treatment, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 239 Pages | 商品交期: 2-3個工作天內

價格

2021 年全球含銀傷口敷料市場價值 8.891 億美元，預計到 2031 年將達到 151.18 萬美元，2022-2031 年含銀傷口敷料是與銀結合的抗菌敷料。

銀用於傷口敷料，以增強其電離狀態下的抗真菌和抗菌性能，並防止病原菌形成生物膜。 此外，這些敷料在低滲或高滲傷口,潰瘍和燒傷中提供抗菌活性。

推動市場增長的主要因素是運動相關傷害和交通事故的流行率上升,老年人口增加以及外科手術激增。 例如，根據國際糖尿病聯合會的數據，到 2021 年，將有大約 5.37 億成年人（20-79 歲）患有糖尿病。 糖尿病患者總數預計到 2030 年將增加到 6.43 億，到 2045 年將增加到 7.83 億。 此外，估計有超過 120 萬兒童和青少年（0-19 歲）患有 1 型糖尿病，5.41 億成年人患 2 型糖尿病的風險增加。

此外，人們越來越意識到含銀敷料的有益特性，例如抗菌特性,更快的癒合時間和降低的感染風險，這是推動市場增長的主要因素。

然而，銀傷口護理的高成本預計會阻礙市場增長。 另一方面，老年人口的增加,先進傷口護理意識的提高以及新興經濟體的高增長選擇預計將在預測期內為市場增長提供有利可圖的機會。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
  • 波特的五力分析
  • 主要公司的定位
  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • COVID-19 影響分析

第 4 章含銀傷口敷料市場：按產品類型

  • 概覽
    • 市場規模和預測
  • 表格
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 凝膠霜
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
    • 凝膠和乳膏銀傷口敷料市場：按類型分類
  • 泡沫
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 5 章含銀傷口敷料市場：按處理方式

  • 概覽
    • 市場規模和預測
  • 手術傷口
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 伯恩斯
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 潰瘍
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 裂傷和割傷
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 植皮
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢,增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 6 章含銀傷口敷料市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院和診所
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 門診手術中心
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 家庭護理
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 7 章含銀傷口敷料市場：按地區

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機會
    • 北美市場規模和預測：按產品類型
    • 北美市場規模和預測：按處理方法
    • 北美市場規模和預測：按最終用戶分類
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機會
    • 歐洲市場規模和預測：按產品類型
    • 歐洲市場規模和預測：按處理方法
    • 歐洲市場規模和預測：按最終用戶分類
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 法國
      • 英國
      • 意大利
      • 西班牙
      • 其他歐洲
  • 亞太地區
    • 主要趨勢和機會
    • 亞太地區市場規模和按產品類型預測
    • 亞太地區市場規模和按處理方法預測
    • 亞太市場規模和預測：按最終用戶分類
    • 亞太地區的市場規模和預測：按國家/地區分類
      • 日本
      • 中國
      • 澳大利亞
      • 印度
      • 韓國
      • 其他亞太地區
  • 拉美
    • 主要趨勢和機會
    • LAMEA 市場規模和預測：按產品類型
    • LAMEA 市場規模和預測：按處理方法
    • LAMEA 市場規模和預測：按最終用戶分類
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其餘部分

第八章公司情況

  • 介紹
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 主要發展

第九章公司簡介

  • 3M Company
  • Argentum Medical LLC
  • B Braun Melsungen AG
  • Convatec, Inc.
  • Ferris Mfg.Corp
  • Johnson And Johnson
  • Monlycke Health Care
  • Molnlycke Health Care
  • medline industries, inc.
  • DermaRite Industries, LLC.
Product Code: A00179

The global silver wound dressings market was valued at $889.1 million in 2021, and is projected to reach $1,511.8 million by 2031, registering a CAGR of 5.4% from 2022 to 2031.Silver wound dressings are antimicrobial dressings, which are integrated with silver. The metal, in ionized form, exhibits enhanced antifungal and antimicrobial properties, and are used in wound dressings for preventing biofilm formation by pathogenic bacteria These dressings are wound care products intended to manage bioburden in acute and chronic wounds. In addition, these dressings provide antimicrobial action on low to high exudates wounds, ulcers, and burns.

The key factors that drive the growth of the market are increase in prevalence of sport related injuries and & road accidents, rise in geriatric population, and surge in number of surgical procedures. For instance, according to International Diabetes Federation, in 2021, approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Furthermore, it was estimated that more than 1.2 million children and adolescents (0-19 years) are living with type 1 diabetes and 541 million adults are at increased risk of developing type 2 diabetes.

Moreover, the rise in awareness of the beneficial properties of silver incorporated dressing such as antimicrobial nature, reduction in healing time and lowered infection risks are the key factors boost the growth of the market.

However, the high cost of silver wound care is expected to hinder the growth of the market. On the other hand, rise in geriatric population, increasing awareness towards advanced wound care therapies and high growth optional in developing economies are anticipated to provide lucrative opportunities for the growth of the market during the forecast period. 

The silver wound dressings market is segmented on the basis of product type, treatment, end user, and region. By product type, it is categorized into sheets, gel & creams, foams, and others. The gels & creams segment is further classified into alginate, hydrogel, silver sulfadiazine and others. By treatment, the market is categorized into ulcers, skin grafts, lacerations & cuts, surgical wounds, burns, and others. By end user, the market is fragmented into hospital & clinics, ambulatory surgical centers, and homecare. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the silver wound dressings market share in 2021 and is anticipated to remain dominant during the forecast period. The market is mainly driven by the presence of well-established healthcare facilities and a high prevalence rate of diabetes and chronic & acute wounds. Moreover, the presence of a number of key players involved in R&D activities for the development of technologically advanced products is contributing toward the market growth in this region.

Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the presence of large geriatric population and constantly improving healthcare infrastructure. In addition, the rapidly growing population, and increase in number of surgical procedures and road accidents, is set to drive the market growth in the Asia-Pacific region.

The key players that operate in the silver wound dressings market include 3M (Acelity Inc.), Medline Industries, LP, Argentum Medical LLC, B. Braun Melsungen AG, Convatec Inc, Dermarite Industries, Inc, Ferris Mfg. Corp., Ltd., Johnson and Johnson, Molnlycke Health Care AB, and Smith and Nephew PLC.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the silver wound dressings market analysis from 2021 to 2031 to identify the prevailing silver wound dressings market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the silver wound dressings market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global silver wound dressings market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

  • Sheets
  • Gels and Creams
    • Type
    • Alginate
    • Hydrogel
    • Silver sulfadiazine
    • Others
  • Foams
  • Others

By Treatment

  • Surgical Wounds
  • Burns
  • Ulcers
  • Lacerations and Cuts
  • Skin Grafts
  • Others

By End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Homecare

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • 3M Company
    • Argentum Medical LLC
    • , B Braun Melsungen AG
    • Convatec, Inc.
    • Ferris Mfg.Corp
    • Johnson And Johnson
    • Monlycke Health Care
    • Molnlycke Health Care
    • medline industries, inc.
    • DermaRite Industries, LLC.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Sheets
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Gels and Creams
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country
    • 4.3.4 Gels and Creams Silver Wound Dressings Market by Type
  • 4.4 Foams
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market share analysis by country
  • 4.5 Others
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market share analysis by country

CHAPTER 5: SILVER WOUND DRESSINGS MARKET, BY TREATMENT

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Surgical Wounds
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 Burns
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country
  • 5.4 Ulcers
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market share analysis by country
  • 5.5 Lacerations and Cuts
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market share analysis by country
  • 5.6 Skin Grafts
    • 5.6.1 Key market trends, growth factors and opportunities
    • 5.6.2 Market size and forecast, by region
    • 5.6.3 Market share analysis by country
  • 5.7 Others
    • 5.7.1 Key market trends, growth factors and opportunities
    • 5.7.2 Market size and forecast, by region
    • 5.7.3 Market share analysis by country

CHAPTER 6: SILVER WOUND DRESSINGS MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals and Clinics
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3 Ambulatory Surgical Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country
  • 6.4 Homecare
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market share analysis by country

CHAPTER 7: SILVER WOUND DRESSINGS MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product Type
    • 7.2.3 North America Market size and forecast, by Treatment
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Product Type
      • 7.2.5.1.3 Market size and forecast, by Treatment
      • 7.2.5.1.4 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Product Type
      • 7.2.5.2.3 Market size and forecast, by Treatment
      • 7.2.5.2.4 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Product Type
      • 7.2.5.3.3 Market size and forecast, by Treatment
      • 7.2.5.3.4 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product Type
    • 7.3.3 Europe Market size and forecast, by Treatment
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Product Type
      • 7.3.5.1.3 Market size and forecast, by Treatment
      • 7.3.5.1.4 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Product Type
      • 7.3.5.2.3 Market size and forecast, by Treatment
      • 7.3.5.2.4 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Product Type
      • 7.3.5.3.3 Market size and forecast, by Treatment
      • 7.3.5.3.4 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Product Type
      • 7.3.5.4.3 Market size and forecast, by Treatment
      • 7.3.5.4.4 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Product Type
      • 7.3.5.5.3 Market size and forecast, by Treatment
      • 7.3.5.5.4 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Product Type
      • 7.3.5.6.3 Market size and forecast, by Treatment
      • 7.3.5.6.4 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Treatment
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Product Type
      • 7.4.5.1.3 Market size and forecast, by Treatment
      • 7.4.5.1.4 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Product Type
      • 7.4.5.2.3 Market size and forecast, by Treatment
      • 7.4.5.2.4 Market size and forecast, by End User
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Product Type
      • 7.4.5.3.3 Market size and forecast, by Treatment
      • 7.4.5.3.4 Market size and forecast, by End User
      • 7.4.5.4 India
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Product Type
      • 7.4.5.4.3 Market size and forecast, by Treatment
      • 7.4.5.4.4 Market size and forecast, by End User
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Product Type
      • 7.4.5.5.3 Market size and forecast, by Treatment
      • 7.4.5.5.4 Market size and forecast, by End User
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Product Type
      • 7.4.5.6.3 Market size and forecast, by Treatment
      • 7.4.5.6.4 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product Type
    • 7.5.3 LAMEA Market size and forecast, by Treatment
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Product Type
      • 7.5.5.1.3 Market size and forecast, by Treatment
      • 7.5.5.1.4 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Product Type
      • 7.5.5.2.3 Market size and forecast, by Treatment
      • 7.5.5.2.4 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Product Type
      • 7.5.5.3.3 Market size and forecast, by Treatment
      • 7.5.5.3.4 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Product Type
      • 7.5.5.4.3 Market size and forecast, by Treatment
      • 7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 3M Company
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Argentum Medical LLC
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 , B Braun Melsungen AG
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Convatec, Inc.
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Ferris Mfg.Corp
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Johnson And Johnson
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Monlycke Health Care
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Molnlycke Health Care
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 medline industries, inc.
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 DermaRite Industries, LLC.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 2. SILVER WOUND DRESSINGS MARKET FOR SHEETS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 3. SILVER WOUND DRESSINGS MARKET FOR SHEETS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 4. SILVER WOUND DRESSINGS MARKET FOR GELS AND CREAMS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 5. SILVER WOUND DRESSINGS MARKET FOR GELS AND CREAMS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 6. GLOBAL GELS AND CREAMS SILVER WOUND DRESSINGS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 7. SILVER WOUND DRESSINGS MARKET FOR FOAMS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 8. SILVER WOUND DRESSINGS MARKET FOR FOAMS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 9. SILVER WOUND DRESSINGS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. SILVER WOUND DRESSINGS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. GLOBAL SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. SILVER WOUND DRESSINGS MARKET FOR SURGICAL WOUNDS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. SILVER WOUND DRESSINGS MARKET FOR SURGICAL WOUNDS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. SILVER WOUND DRESSINGS MARKET FOR BURNS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. SILVER WOUND DRESSINGS MARKET FOR BURNS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. SILVER WOUND DRESSINGS MARKET FOR ULCERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. SILVER WOUND DRESSINGS MARKET FOR ULCERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. SILVER WOUND DRESSINGS MARKET FOR LACERATIONS AND CUTS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. SILVER WOUND DRESSINGS MARKET FOR LACERATIONS AND CUTS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. SILVER WOUND DRESSINGS MARKET FOR SKIN GRAFTS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. SILVER WOUND DRESSINGS MARKET FOR SKIN GRAFTS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. SILVER WOUND DRESSINGS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. SILVER WOUND DRESSINGS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. GLOBAL SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. SILVER WOUND DRESSINGS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. SILVER WOUND DRESSINGS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. SILVER WOUND DRESSINGS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. SILVER WOUND DRESSINGS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. SILVER WOUND DRESSINGS MARKET FOR HOMECARE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. SILVER WOUND DRESSINGS MARKET FOR HOMECARE, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. SILVER WOUND DRESSINGS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. NORTH AMERICA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. NORTH AMERICA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. NORTH AMERICA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. NORTH AMERICA SILVER WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. U.S. SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. U.S. SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. U.S. SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. CANADA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. CANADA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. CANADA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. MEXICO SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. MEXICO SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. MEXICO SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. EUROPE SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. EUROPE SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. EUROPE SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. EUROPE SILVER WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. GERMANY SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. GERMANY SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. GERMANY SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. FRANCE SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. FRANCE SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. FRANCE SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. UK SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. UK SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. UK SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. ITALY SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. ITALY SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. ITALY SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. SPAIN SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. SPAIN SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. SPAIN SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. REST OF EUROPE SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. REST OF EUROPE SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. REST OF EUROPE SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. JAPAN SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. JAPAN SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. JAPAN SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. CHINA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. CHINA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. CHINA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. AUSTRALIA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. AUSTRALIA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. AUSTRALIA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. INDIA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. INDIA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. INDIA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. SOUTH KOREA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. SOUTH KOREA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. SOUTH KOREA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. REST OF ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. REST OF ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. REST OF ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 89. LAMEA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 90. LAMEA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 91. LAMEA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 92. LAMEA SILVER WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 93. BRAZIL SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 94. BRAZIL SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 95. BRAZIL SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 96. SAUDI ARABIA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 97. SAUDI ARABIA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 98. SAUDI ARABIA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 99. SOUTH AFRICA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 100. SOUTH AFRICA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 101. SOUTH AFRICA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 102. REST OF LAMEA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 103. REST OF LAMEA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 104. REST OF LAMEA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 105.3M COMPANY: COMPANY SNAPSHOT
  • TABLE 106.3M COMPANY: OPERATING SEGMENTS
  • TABLE 107.3M COMPANY: PRODUCT PORTFOLIO
  • TABLE 108.3M COMPANY: NET SALES
  • TABLE 109.3M COMPANY: KEY STRATERGIES
  • TABLE 110.ARGENTUM MEDICAL LLC: COMPANY SNAPSHOT
  • TABLE 111.ARGENTUM MEDICAL LLC: OPERATING SEGMENTS
  • TABLE 112.ARGENTUM MEDICAL LLC: PRODUCT PORTFOLIO
  • TABLE 113.ARGENTUM MEDICAL LLC: NET SALES
  • TABLE 114.ARGENTUM MEDICAL LLC: KEY STRATERGIES
  • TABLE 115., B BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 116., B BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 117., B BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 118., B BRAUN MELSUNGEN AG: NET SALES
  • TABLE 119., B BRAUN MELSUNGEN AG: KEY STRATERGIES
  • TABLE 120.CONVATEC, INC.: COMPANY SNAPSHOT
  • TABLE 121.CONVATEC, INC.: OPERATING SEGMENTS
  • TABLE 122.CONVATEC, INC.: PRODUCT PORTFOLIO
  • TABLE 123.CONVATEC, INC.: NET SALES
  • TABLE 124.CONVATEC, INC.: KEY STRATERGIES
  • TABLE 125.FERRIS MFG.CORP: COMPANY SNAPSHOT
  • TABLE 126.FERRIS MFG.CORP: OPERATING SEGMENTS
  • TABLE 127.FERRIS MFG.CORP: PRODUCT PORTFOLIO
  • TABLE 128.FERRIS MFG.CORP: NET SALES
  • TABLE 129.FERRIS MFG.CORP: KEY STRATERGIES
  • TABLE 130.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 131.JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 132.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 133.JOHNSON AND JOHNSON: NET SALES
  • TABLE 134.JOHNSON AND JOHNSON: KEY STRATERGIES
  • TABLE 135.MONLYCKE HEALTH CARE: COMPANY SNAPSHOT
  • TABLE 136.MONLYCKE HEALTH CARE: OPERATING SEGMENTS
  • TABLE 137.MONLYCKE HEALTH CARE: PRODUCT PORTFOLIO
  • TABLE 138.MONLYCKE HEALTH CARE: NET SALES
  • TABLE 139.MONLYCKE HEALTH CARE: KEY STRATERGIES
  • TABLE 140.MOLNLYCKE HEALTH CARE: COMPANY SNAPSHOT
  • TABLE 141.MOLNLYCKE HEALTH CARE: OPERATING SEGMENTS
  • TABLE 142.MOLNLYCKE HEALTH CARE: PRODUCT PORTFOLIO
  • TABLE 143.MOLNLYCKE HEALTH CARE: NET SALES
  • TABLE 144.MOLNLYCKE HEALTH CARE: KEY STRATERGIES
  • TABLE 145.MEDLINE INDUSTRIES, INC.: COMPANY SNAPSHOT
  • TABLE 146.MEDLINE INDUSTRIES, INC.: OPERATING SEGMENTS
  • TABLE 147.MEDLINE INDUSTRIES, INC.: PRODUCT PORTFOLIO
  • TABLE 148.MEDLINE INDUSTRIES, INC.: NET SALES
  • TABLE 149.MEDLINE INDUSTRIES, INC.: KEY STRATERGIES
  • TABLE 150.DERMARITE INDUSTRIES, LLC.: COMPANY SNAPSHOT
  • TABLE 151.DERMARITE INDUSTRIES, LLC.: OPERATING SEGMENTS
  • TABLE 152.DERMARITE INDUSTRIES, LLC.: PRODUCT PORTFOLIO
  • TABLE 153.DERMARITE INDUSTRIES, LLC.: NET SALES
  • TABLE 154.DERMARITE INDUSTRIES, LLC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.SILVER WOUND DRESSINGS MARKET SEGMENTATION
  • FIGURE 2.SILVER WOUND DRESSINGS MARKET,2021-2031
  • FIGURE 3.SILVER WOUND DRESSINGS MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.SILVER WOUND DRESSINGS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.SILVER WOUND DRESSINGS MARKET,BY PRODUCT TYPE,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SHEETS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF GELS AND CREAMS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF FOAMS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OTHERS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
  • FIGURE 17.SILVER WOUND DRESSINGS MARKET,BY TREATMENT,2021(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SURGICAL WOUNDS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF BURNS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF ULCERS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF LACERATIONS AND CUTS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SKIN GRAFTS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF OTHERS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
  • FIGURE 24.SILVER WOUND DRESSINGS MARKET,BY END USER,2021(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF HOMECARE SILVER WOUND DRESSINGS MARKET,2021-2031(%)
  • FIGURE 28.SILVER WOUND DRESSINGS MARKET BY REGION,2021
  • FIGURE 29.U.S. SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 30.CANADA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 31.MEXICO SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 32.GERMANY SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 33.FRANCE SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 34.UK SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 35.ITALY SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 36.SPAIN SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 37.REST OF EUROPE SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 38.JAPAN SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 39.CHINA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 40.AUSTRALIA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 41.INDIA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 42.SOUTH KOREA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 43.REST OF ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 44.BRAZIL SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 45.SAUDI ARABIA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 46.SOUTH AFRICA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 47.REST OF LAMEA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
  • FIGURE 48. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 51.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 52.COMPETITIVE DASHBOARD
  • FIGURE 53.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 54.3M COMPANY.: NET SALES ($MILLION)
  • FIGURE 55.ARGENTUM MEDICAL LLC.: NET SALES ($MILLION)
  • FIGURE 56., B BRAUN MELSUNGEN AG.: NET SALES ($MILLION)
  • FIGURE 57.CONVATEC, INC..: NET SALES ($MILLION)
  • FIGURE 58.FERRIS MFG.CORP.: NET SALES ($MILLION)
  • FIGURE 59.JOHNSON AND JOHNSON.: NET SALES ($MILLION)
  • FIGURE 60.MONLYCKE HEALTH CARE.: NET SALES ($MILLION)
  • FIGURE 61.MOLNLYCKE HEALTH CARE.: NET SALES ($MILLION)
  • FIGURE 62.MEDLINE INDUSTRIES, INC..: NET SALES ($MILLION)
  • FIGURE 63.DERMARITE INDUSTRIES, LLC..: NET SALES ($MILLION)